相关实验视频
Updated: Sep 15, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
病例报告: 一种罕见的原发性急性巨细胞白血病的经验
Zhijuan Pan1, Ying Zhang1, Yanru Guo1
1Department of Hematology, Peking University First Hospital Taiyuan Branch (Taiyuan Central Hospital of Shanxi Medical University), No. 256, Fendong Street, Xiaodian District, Taiyuan, Shanxi 030009, PR China.
甲基普雷迪尼索隆可能比德克萨米他更有效地治疗巨细胞白血病 (MCL),这是一种罕见的癌症. 这一发现表明,个性化皮质类固醇治疗对于改善MCL患者的治疗结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺细胞白血病 (MCL) 是一种具有不良预后的侵袭性全身性乳腺细胞瘤.
- 了解MCL中的差异性皮质类固醇反应对于患者的治疗结果至关重要.
更多相关视频
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023